A Novel Blood-Sparing Agent in Cardiac Surgery? First In-Patient Experience with the Synthetic Serine Protease Inhibitor MDCO-2010-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Novel Blood-Sparing Agent in Cardiac Surgery? First In-Patient Experience with the Synthetic Serine Protease Inhibitor MDCO-2010

Published:2014-07 Issue:1 Volume:119 Page:16-25
ISSN:0003-2999
Container-title:Anesthesia & Analgesia
language:en
Short-container-title:

Author:

Englberger Lars,Dietrich Wulf,Eberle Balthasar,Erdoes Gabor,Keller Dorothee,Carrel Thierry

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine

Reference21 articles.

1. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting.;Koch;Crit Care Med,2006

2. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery.;Murphy;Circulation,2007

3. Thrombin during cardiopulmonary bypass.;Edmunds;Ann Thorac Surg,2006

4. Enhanced thrombin generation after cardiopulmonary bypass surgery.;Lison;Anesth Analg,2011

5. High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass.;Kalavrouziotis;Ann Thorac Surg,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in the discovery and development of drugs targeting the kallikrein-kinin system;Journal of Translational Medicine;2024-04-26

2. Synthesis and Structural Characterization of Macrocyclic Plasmin Inhibitors;ChemMedChem;2023-02-07

3. Enhanced Antifibrinolytic Efficacy of a Plasmin-Specific Kunitz-Inhibitor (60-Residue Y11T/L17R with C-Terminal IEK) of Human Tissue Factor Pathway Inhibitor Type-2 Domain1;Journal of Clinical Medicine;2020-11-17

4. Application of tissue-engineered interventions for coronary artery bypass grafts;Future Cardiology;2020-11

5. Antifibrinolytics and cardiac surgery: The past, the present, and the future;Annals of Cardiac Anaesthesia;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3